3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Follicular
19
Lymphoma
19
Lymphoma, Mantle-Cell
17
Leukemia, Lymphocytic, Chronic, B-Cell
15
Lymphoma, Large B-Cell, Diffuse
10
Lymphoma, B-Cell, Marginal Zone
10
Lymphoma, B-Cell
10
Lymphoma, Non-Hodgkin
9
Recurrence
6
Hodgkin Disease
6
Waldenstrom Macroglobulinemia
5
Neoplasms
3
Multiple Myeloma
3
Leukemia
3
Burkitt Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, T-Cell, Peripheral
2
Lymphatic Diseases
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Hematologic Diseases
2
Sezary Syndrome
1
Proteostasis Deficiencies
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Neoplasms
1
Neurotoxicity Syndromes
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Interventions
fludarabine
19
Whole-Body Irradiation
18
Cyclophosphamide
17
fludarabine phosphate
16
ruxolitinib
15
Mycophenolic Acid
14
Specimen Handling
13
Tacrolimus
11
Azacitidine
11
Biopsy
10
Peripheral Blood Stem Cell Transplantation
9
Melphalan
9
Cytarabine
9
venetoclax
8
Sirolimus
8
Busulfan
8
Stem Cell Transplantation
6
Injections
6
Granulocyte Colony-Stimulating Factor
6
Daunorubicin
5
Cyclosporine
5
CPX-351
5
luspatercept
4
ivosidenib
4
itacitinib
4
fedratinib
4
decitabine and cedazuridine drug combination
4
Thiotepa
4
Liposomes
4
Cyclosporins
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
Bendamustine Hydrochloride
×
1 year
×
Clear all
No trials found.